Vitesse Biologics, LLC

Vitesse Biologics, is a joint venture company, developing antibody and protein-based therapeutics in the areas of immunology, hematology, and oncology.

In June 2015 Baxalta Ventures, Mayo Clinic and Velocity Pharmaceutical Development (VPD) formed Vitesse Biologics to focus on the development of antibody and protein-based therapeutics in the areas of immunology, hematology, and oncology. Baxter BioScience will provide global commercialization, antibody and protein development and manufacturing capabilities; Mayo Clinic researchers will execute the Phase I clinical trials; VPD will be responsible for target identification, selection of early stage drug candidates and will lead the design and execution of pre-clinical and clinical protocols.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://vitessebiologics.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
400 Oyster Point Boulevard, Suite 202,CA
South San Francisco
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]